NCT00192595View on ClinicalTrials.gov

Tenofovir in HIV/HBV Coinfection

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2007

Conditions
HIV InfectionHepatitis B Coinfection
Interventions
DRUG

Tenofovir

DRUG

Zidovudine (AZT), lamivudine (LAM), efavirenz (EFV)

Trial Locations (3)

2010

St. Vincent's Hospital, Darlinghurst

3004

The Alfred Hospital, Melbourne

Unknown

Thai Red Cross AIDS Research Centre, Bangkok

Sponsors

Lead Sponsor

Kirby Institute

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

The University of New South Wales

OTHER

collaborator

Gilead Sciences

INDUSTRY

lead

Kirby Institute

OTHER_GOV

NCT00192595 - Tenofovir in HIV/HBV Coinfection | Biotech Hunter | Biotech Hunter